Nu Skin Enterprises (NUS) Current Deferred Revenue (2015 - 2025)

Nu Skin Enterprises has reported Current Deferred Revenue for 11 years, with the latest figure at $12.7 million in Q4 2025.

• Quarterly Current Deferred Revenue fell 18.81% year-over-year to $12.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.7 million (down 18.81% YoY) and the FY2025 annual result came in at $12.7 million, down 18.81% from the prior year.
• Current Deferred Revenue declined to $12.7 million in Q4 2025 per NUS's latest filing, from $15.7 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $33.1 million in Q4 2021 and troughed at $12.7 million in Q4 2025.
• A 5-year average of $21.8 million and a median of $20.3 million in 2023 frame the typical range for Current Deferred Revenue.
• The sharpest annual moves came in 2021 and 2023: Current Deferred Revenue slipped 5.46% in 2021, then declined 24.82% in 2023.
• Over 5 years, Current Deferred Revenue stood at $33.1 million in 2021, then declined by 18.37% to $27.1 million in 2022, then slipped by 24.82% to $20.3 million in 2023, then decreased by 22.86% to $15.7 million in 2024, then fell by 18.81% to $12.7 million in 2025.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $12.7 million, $15.7 million, and $20.3 million for Q4 2025, Q4 2024, and Q4 2023 respectively.